Eli Lilly acquires Centessa for sleep disorder medication
Pharmaceutical giant Eli Lilly is acquiring Centessa Pharmaceuticals for up to 8 billion dollars. The goal is to secure an experimental medication for excessive sleepiness. The acquisition underscores the interest of major pharmaceutical companies in innovative solutions for sleep disorders.